Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4I0S0
Term | Name | Level | Count |
---|---|---|---|
GO:0000459 | exonucleolytic trimming involved in rRNA processing | 8 | 1 |
GO:0000467 | exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 9 | 1 |
GO:0000469 | cleavage involved in rRNA processing | 7 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006364 | rRNA processing | 8 | 1 |
GO:0006396 | RNA processing | 6 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016072 | rRNA metabolic process | 7 | 1 |
GO:0031123 | RNA 3'-end processing | 7 | 1 |
GO:0031125 | rRNA 3'-end processing | 9 | 1 |
GO:0034470 | ncRNA processing | 7 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034660 | ncRNA metabolic process | 6 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043628 | regulatory ncRNA 3'-end processing | 8 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 5 | 1 |
GO:0090501 | RNA phosphodiester bond hydrolysis | 6 | 1 |
GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic | 7 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000215 | tRNA 2'-phosphotransferase activity | 5 | 11 |
GO:0003676 | nucleic acid binding | 3 | 11 |
GO:0003824 | catalytic activity | 1 | 11 |
GO:0005488 | binding | 1 | 11 |
GO:0016740 | transferase activity | 2 | 11 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 11 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 11 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 11 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
GO:0000175 | 3'-5'-RNA exonuclease activity | 7 | 1 |
GO:0004518 | nuclease activity | 4 | 1 |
GO:0004527 | exonuclease activity | 5 | 1 |
GO:0004532 | RNA exonuclease activity | 5 | 1 |
GO:0004540 | RNA nuclease activity | 4 | 1 |
GO:0008408 | 3'-5' exonuclease activity | 6 | 1 |
GO:0016787 | hydrolase activity | 2 | 1 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 1 |
GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6 | 1 |
GO:0016896 | RNA exonuclease activity, producing 5'-phosphomonoesters | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 286 | 290 | PF00656 | 0.661 |
CLV_C14_Caspase3-7 | 308 | 312 | PF00656 | 0.729 |
CLV_C14_Caspase3-7 | 7 | 11 | PF00656 | 0.581 |
CLV_NRD_NRD_1 | 252 | 254 | PF00675 | 0.507 |
CLV_NRD_NRD_1 | 267 | 269 | PF00675 | 0.578 |
CLV_NRD_NRD_1 | 33 | 35 | PF00675 | 0.711 |
CLV_NRD_NRD_1 | 405 | 407 | PF00675 | 0.476 |
CLV_NRD_NRD_1 | 509 | 511 | PF00675 | 0.305 |
CLV_NRD_NRD_1 | 71 | 73 | PF00675 | 0.334 |
CLV_PCSK_KEX2_1 | 252 | 254 | PF00082 | 0.483 |
CLV_PCSK_KEX2_1 | 267 | 269 | PF00082 | 0.578 |
CLV_PCSK_KEX2_1 | 33 | 35 | PF00082 | 0.737 |
CLV_PCSK_KEX2_1 | 71 | 73 | PF00082 | 0.334 |
CLV_PCSK_SKI1_1 | 102 | 106 | PF00082 | 0.259 |
CLV_PCSK_SKI1_1 | 166 | 170 | PF00082 | 0.291 |
CLV_PCSK_SKI1_1 | 241 | 245 | PF00082 | 0.233 |
CLV_PCSK_SKI1_1 | 456 | 460 | PF00082 | 0.447 |
CLV_PCSK_SKI1_1 | 89 | 93 | PF00082 | 0.325 |
DEG_ODPH_VHL_1 | 50 | 63 | PF01847 | 0.481 |
DOC_CKS1_1 | 179 | 184 | PF01111 | 0.586 |
DOC_CKS1_1 | 18 | 23 | PF01111 | 0.728 |
DOC_CKS1_1 | 539 | 544 | PF01111 | 0.360 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 241 | 247 | PF00134 | 0.530 |
DOC_MAPK_gen_1 | 192 | 200 | PF00069 | 0.542 |
DOC_MAPK_gen_1 | 252 | 259 | PF00069 | 0.464 |
DOC_MAPK_gen_1 | 406 | 412 | PF00069 | 0.476 |
DOC_MAPK_gen_1 | 510 | 517 | PF00069 | 0.305 |
DOC_MAPK_MEF2A_6 | 252 | 261 | PF00069 | 0.465 |
DOC_MAPK_MEF2A_6 | 510 | 519 | PF00069 | 0.335 |
DOC_PP1_RVXF_1 | 378 | 385 | PF00149 | 0.480 |
DOC_PP2B_LxvP_1 | 225 | 228 | PF13499 | 0.558 |
DOC_PP2B_PxIxI_1 | 81 | 87 | PF00149 | 0.433 |
DOC_PP4_FxxP_1 | 330 | 333 | PF00568 | 0.509 |
DOC_USP7_MATH_1 | 151 | 155 | PF00917 | 0.513 |
DOC_USP7_MATH_1 | 19 | 23 | PF00917 | 0.767 |
DOC_USP7_MATH_1 | 282 | 286 | PF00917 | 0.493 |
DOC_USP7_MATH_1 | 292 | 296 | PF00917 | 0.696 |
DOC_USP7_MATH_1 | 38 | 42 | PF00917 | 0.742 |
DOC_USP7_MATH_1 | 387 | 391 | PF00917 | 0.408 |
DOC_USP7_UBL2_3 | 367 | 371 | PF12436 | 0.445 |
DOC_USP7_UBL2_3 | 553 | 557 | PF12436 | 0.486 |
DOC_WW_Pin1_4 | 17 | 22 | PF00397 | 0.738 |
DOC_WW_Pin1_4 | 178 | 183 | PF00397 | 0.565 |
DOC_WW_Pin1_4 | 297 | 302 | PF00397 | 0.683 |
DOC_WW_Pin1_4 | 538 | 543 | PF00397 | 0.347 |
DOC_WW_Pin1_4 | 89 | 94 | PF00397 | 0.530 |
LIG_14-3-3_CanoR_1 | 111 | 119 | PF00244 | 0.586 |
LIG_14-3-3_CanoR_1 | 241 | 250 | PF00244 | 0.475 |
LIG_14-3-3_CanoR_1 | 323 | 329 | PF00244 | 0.701 |
LIG_14-3-3_CanoR_1 | 33 | 37 | PF00244 | 0.630 |
LIG_14-3-3_CanoR_1 | 385 | 395 | PF00244 | 0.434 |
LIG_14-3-3_CanoR_1 | 456 | 462 | PF00244 | 0.447 |
LIG_Actin_WH2_2 | 239 | 254 | PF00022 | 0.502 |
LIG_AP2alpha_2 | 128 | 130 | PF02296 | 0.586 |
LIG_APCC_ABBA_1 | 515 | 520 | PF00400 | 0.355 |
LIG_BIR_III_2 | 148 | 152 | PF00653 | 0.562 |
LIG_BIR_III_2 | 281 | 285 | PF00653 | 0.641 |
LIG_BRCT_BRCA1_1 | 326 | 330 | PF00533 | 0.573 |
LIG_BRCT_BRCA1_1 | 357 | 361 | PF00533 | 0.648 |
LIG_BRCT_BRCA1_1 | 43 | 47 | PF00533 | 0.718 |
LIG_FHA_1 | 242 | 248 | PF00498 | 0.433 |
LIG_FHA_1 | 332 | 338 | PF00498 | 0.579 |
LIG_FHA_1 | 539 | 545 | PF00498 | 0.330 |
LIG_FHA_2 | 157 | 163 | PF00498 | 0.481 |
LIG_FHA_2 | 284 | 290 | PF00498 | 0.647 |
LIG_FHA_2 | 306 | 312 | PF00498 | 0.726 |
LIG_FHA_2 | 457 | 463 | PF00498 | 0.403 |
LIG_Integrin_isoDGR_2 | 563 | 565 | PF01839 | 0.414 |
LIG_LIR_Apic_2 | 327 | 333 | PF02991 | 0.544 |
LIG_LIR_Gen_1 | 154 | 162 | PF02991 | 0.513 |
LIG_LIR_Gen_1 | 390 | 400 | PF02991 | 0.399 |
LIG_LIR_Gen_1 | 56 | 65 | PF02991 | 0.335 |
LIG_LIR_Nem_3 | 128 | 133 | PF02991 | 0.482 |
LIG_LIR_Nem_3 | 154 | 158 | PF02991 | 0.513 |
LIG_LIR_Nem_3 | 390 | 396 | PF02991 | 0.399 |
LIG_LIR_Nem_3 | 44 | 50 | PF02991 | 0.573 |
LIG_LIR_Nem_3 | 56 | 61 | PF02991 | 0.296 |
LIG_LIR_Nem_3 | 80 | 84 | PF02991 | 0.479 |
LIG_LIR_Nem_3 | 96 | 100 | PF02991 | 0.441 |
LIG_LYPXL_SIV_4 | 430 | 438 | PF13949 | 0.480 |
LIG_MYND_1 | 211 | 215 | PF01753 | 0.502 |
LIG_NRBOX | 246 | 252 | PF00104 | 0.407 |
LIG_PDZ_Class_2 | 565 | 570 | PF00595 | 0.604 |
LIG_RPA_C_Fungi | 336 | 348 | PF08784 | 0.554 |
LIG_SH2_CRK | 155 | 159 | PF00017 | 0.447 |
LIG_SH2_PTP2 | 100 | 103 | PF00017 | 0.335 |
LIG_SH2_PTP2 | 393 | 396 | PF00017 | 0.408 |
LIG_SH2_PTP2 | 58 | 61 | PF00017 | 0.342 |
LIG_SH2_SRC | 518 | 521 | PF00017 | 0.355 |
LIG_SH2_STAT5 | 100 | 103 | PF00017 | 0.329 |
LIG_SH2_STAT5 | 134 | 137 | PF00017 | 0.474 |
LIG_SH2_STAT5 | 155 | 158 | PF00017 | 0.374 |
LIG_SH2_STAT5 | 393 | 396 | PF00017 | 0.369 |
LIG_SH2_STAT5 | 439 | 442 | PF00017 | 0.319 |
LIG_SH2_STAT5 | 484 | 487 | PF00017 | 0.368 |
LIG_SH2_STAT5 | 518 | 521 | PF00017 | 0.355 |
LIG_SH2_STAT5 | 554 | 557 | PF00017 | 0.393 |
LIG_SH2_STAT5 | 58 | 61 | PF00017 | 0.342 |
LIG_SH3_3 | 101 | 107 | PF00018 | 0.377 |
LIG_SH3_3 | 209 | 215 | PF00018 | 0.386 |
LIG_SH3_3 | 295 | 301 | PF00018 | 0.728 |
LIG_SUMO_SIM_par_1 | 255 | 260 | PF11976 | 0.456 |
LIG_SUMO_SIM_par_1 | 333 | 338 | PF11976 | 0.521 |
LIG_SUMO_SIM_par_1 | 82 | 87 | PF11976 | 0.337 |
LIG_TRAF2_1 | 343 | 346 | PF00917 | 0.548 |
LIG_TRAF2_1 | 460 | 463 | PF00917 | 0.441 |
LIG_WW_3 | 300 | 304 | PF00397 | 0.761 |
MOD_CDC14_SPxK_1 | 300 | 303 | PF00782 | 0.599 |
MOD_CDK_SPxK_1 | 17 | 23 | PF00069 | 0.729 |
MOD_CDK_SPxK_1 | 297 | 303 | PF00069 | 0.596 |
MOD_CK1_1 | 41 | 47 | PF00069 | 0.715 |
MOD_CK1_1 | 486 | 492 | PF00069 | 0.349 |
MOD_CK2_1 | 456 | 462 | PF00069 | 0.372 |
MOD_CMANNOS | 473 | 476 | PF00535 | 0.447 |
MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.266 |
MOD_GlcNHglycan | 175 | 178 | PF01048 | 0.447 |
MOD_GlcNHglycan | 203 | 206 | PF01048 | 0.457 |
MOD_GlcNHglycan | 215 | 218 | PF01048 | 0.438 |
MOD_GlcNHglycan | 234 | 237 | PF01048 | 0.249 |
MOD_GlcNHglycan | 26 | 29 | PF01048 | 0.724 |
MOD_GlcNHglycan | 294 | 297 | PF01048 | 0.777 |
MOD_GlcNHglycan | 319 | 322 | PF01048 | 0.789 |
MOD_GlcNHglycan | 40 | 43 | PF01048 | 0.736 |
MOD_GlcNHglycan | 506 | 509 | PF01048 | 0.341 |
MOD_GSK3_1 | 107 | 114 | PF00069 | 0.335 |
MOD_GSK3_1 | 13 | 20 | PF00069 | 0.694 |
MOD_GSK3_1 | 297 | 304 | PF00069 | 0.788 |
MOD_GSK3_1 | 367 | 374 | PF00069 | 0.353 |
MOD_GSK3_1 | 38 | 45 | PF00069 | 0.749 |
MOD_GSK3_1 | 559 | 566 | PF00069 | 0.490 |
MOD_N-GLC_1 | 201 | 206 | PF02516 | 0.402 |
MOD_N-GLC_1 | 241 | 246 | PF02516 | 0.266 |
MOD_NEK2_1 | 13 | 18 | PF00069 | 0.704 |
MOD_NEK2_1 | 173 | 178 | PF00069 | 0.419 |
MOD_NEK2_1 | 348 | 353 | PF00069 | 0.605 |
MOD_NEK2_1 | 372 | 377 | PF00069 | 0.401 |
MOD_NEK2_1 | 531 | 536 | PF00069 | 0.347 |
MOD_PIKK_1 | 117 | 123 | PF00454 | 0.368 |
MOD_PIKK_1 | 193 | 199 | PF00454 | 0.402 |
MOD_PIKK_1 | 4 | 10 | PF00454 | 0.647 |
MOD_PKA_2 | 173 | 179 | PF00069 | 0.447 |
MOD_PKA_2 | 213 | 219 | PF00069 | 0.266 |
MOD_PKA_2 | 32 | 38 | PF00069 | 0.757 |
MOD_PKA_2 | 419 | 425 | PF00069 | 0.438 |
MOD_Plk_1 | 14 | 20 | PF00069 | 0.553 |
MOD_Plk_1 | 241 | 247 | PF00069 | 0.475 |
MOD_Plk_1 | 257 | 263 | PF00069 | 0.500 |
MOD_Plk_4 | 164 | 170 | PF00069 | 0.347 |
MOD_Plk_4 | 331 | 337 | PF00069 | 0.544 |
MOD_Plk_4 | 372 | 378 | PF00069 | 0.390 |
MOD_Plk_4 | 468 | 474 | PF00069 | 0.335 |
MOD_ProDKin_1 | 17 | 23 | PF00069 | 0.739 |
MOD_ProDKin_1 | 178 | 184 | PF00069 | 0.451 |
MOD_ProDKin_1 | 297 | 303 | PF00069 | 0.685 |
MOD_ProDKin_1 | 538 | 544 | PF00069 | 0.347 |
MOD_ProDKin_1 | 89 | 95 | PF00069 | 0.402 |
MOD_SUMO_rev_2 | 162 | 168 | PF00179 | 0.335 |
MOD_SUMO_rev_2 | 362 | 369 | PF00179 | 0.591 |
TRG_DiLeu_BaEn_2 | 135 | 141 | PF01217 | 0.447 |
TRG_ENDOCYTIC_2 | 155 | 158 | PF00928 | 0.378 |
TRG_ENDOCYTIC_2 | 393 | 396 | PF00928 | 0.408 |
TRG_ENDOCYTIC_2 | 518 | 521 | PF00928 | 0.355 |
TRG_ENDOCYTIC_2 | 58 | 61 | PF00928 | 0.327 |
TRG_ER_diArg_1 | 251 | 253 | PF00400 | 0.495 |
TRG_ER_diArg_1 | 266 | 268 | PF00400 | 0.554 |
TRG_ER_diArg_1 | 71 | 73 | PF00400 | 0.415 |
TRG_NES_CRM1_1 | 220 | 230 | PF08389 | 0.452 |
TRG_NLS_MonoExtN_4 | 313 | 320 | PF00514 | 0.582 |
TRG_Pf-PMV_PEXEL_1 | 253 | 258 | PF00026 | 0.539 |
TRG_Pf-PMV_PEXEL_1 | 71 | 75 | PF00026 | 0.403 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HWH5 | Leptomonas seymouri | 58% | 92% |
A0A0S4J7G0 | Bodo saltans | 42% | 88% |
A0A3Q8IBU9 | Leishmania donovani | 100% | 100% |
A0A422MZ86 | Trypanosoma rangeli | 44% | 100% |
A4HDD9 | Leishmania braziliensis | 77% | 99% |
D0A750 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 100% |
E9AWS2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q4QAQ2 | Leishmania major | 90% | 100% |
V5C0L6 | Trypanosoma cruzi | 46% | 89% |